Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Kantarjian, Hagop M.; Hughes, Timothy P.; Larson, Richard A.; Kim, Dong-Wook; Issaragrisil, Surapol; le Coutre, Philipp; Etienne, Gabriel; Boquimpani, Carla; Pasquini, Ricardo; Clark, Richard E.; Dubruille, Viviane; Flinn, Ian W.; Kyrcz-Krzemien, Slawomira; Medras, Ewa; Zanichelli, Maria; Bendit, Israel; Cacciatore, Silvia; Titorenko, Ksenia; Aimone, Paola; Saglio, Giuseppe; Hochhaus, Andreas

doi:10.1038/s41375-021-01306-1

Download PDF

Correction
Published: 09 June 2021

Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Hagop M. Kantarjian ORCID: orcid.org/0000-0002-1908-3307¹^na1,
Timothy P. Hughes^2,3^na1,
Richard A. Larson ORCID: orcid.org/0000-0001-9168-3203⁴,
Dong-Wook Kim ORCID: orcid.org/0000-0003-3967-4267⁵,
Surapol Issaragrisil⁶,
Philipp le Coutre⁷,
Gabriel Etienne⁸,
Carla Boquimpani^9,10,
Ricardo Pasquini¹¹,
Richard E. Clark ORCID: orcid.org/0000-0002-1261-3299¹²,
Viviane Dubruille¹³,
Ian W. Flinn¹⁴,
Slawomira Kyrcz-Krzemien¹⁵,
Ewa Medras¹⁶,
Maria Zanichelli¹⁷,
Israel Bendit¹⁸,
Silvia Cacciatore¹⁹,
Ksenia Titorenko²⁰,
Paola Aimone¹⁹,
Giuseppe Saglio²¹^na2 &
…
Andreas Hochhaus²²^na2

Leukemia volume 35, pages 2142–2143 (2021)Cite this article

1231 Accesses
6 Citations
Metrics details

Subjects

The Original Article was published on 07 January 2021

Correction to: Leukemia 35:20-LEU-1554R

https://doi.org/10.1038/s41375-020-01111-2 published online 07 January 2021

We found an error within Fig. 2B of the manuscript, and unfortunately this was not caught prior to submission and publication. Attached please find the corrected Fig. 2B.

Author information

These authors contributed equally: Hagop M. Kantarjian, Timothy P. Hughes
These authors jointly supervised this work: Giuseppe Saglio, Andreas Hochhaus

Authors and Affiliations

The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Hagop M. Kantarjian
South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Timothy P. Hughes
University of Adelaide, Adelaide, SA, Australia
Timothy P. Hughes
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA
Richard A. Larson
Seoul St. Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea
Dong-Wook Kim
Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Surapol Issaragrisil
Charité - Universitätsmedizin Berlin, Berlin, Germany
Philipp le Coutre
Hematology Department, Institut Bergonié, Bordeaux, France
Gabriel Etienne
Hemorio, Institute of Hematology, Rio de Janeiro, Brazil
Carla Boquimpani
Oncoclínica Rio de Janeiro, Rio de Janeiro, Brazil
Carla Boquimpani
Universidade Federal do Paraná, Hospital de Clinicas, Curitiba, Paraná, Brazil
Ricardo Pasquini
Royal Liverpool University Hospital, Liverpool, United Kingdom
Richard E. Clark
Clinical Hematology, Nantes University Hospital, Nantes, France
Viviane Dubruille
Sarah Cannon Research Institute, Nashville, TN, USA
Ian W. Flinn
Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
Slawomira Kyrcz-Krzemien
Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
Ewa Medras
Instituto de Tratamento do Câncer Infantil, Instituto da Criança, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil
Maria Zanichelli
Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Israel Bendit
Novartis Pharma AG, Basel, Switzerland
Silvia Cacciatore & Paola Aimone
Novartis Pharmaceuticals Corporation, Moscow, Russian Federation
Ksenia Titorenko
Division of Internal Medicine and Hematology, University of Turin, Turin, Italy
Giuseppe Saglio
Universitätsklinikum Jena, Jena, Germany
Andreas Hochhaus

Authors

Hagop M. Kantarjian
View author publications
You can also search for this author in PubMed Google Scholar
Timothy P. Hughes
View author publications
You can also search for this author in PubMed Google Scholar
Richard A. Larson
View author publications
You can also search for this author in PubMed Google Scholar
Dong-Wook Kim
View author publications
You can also search for this author in PubMed Google Scholar
Surapol Issaragrisil
View author publications
You can also search for this author in PubMed Google Scholar
Philipp le Coutre
View author publications
You can also search for this author in PubMed Google Scholar
Gabriel Etienne
View author publications
You can also search for this author in PubMed Google Scholar
Carla Boquimpani
View author publications
You can also search for this author in PubMed Google Scholar
Ricardo Pasquini
View author publications
You can also search for this author in PubMed Google Scholar
Richard E. Clark
View author publications
You can also search for this author in PubMed Google Scholar
Viviane Dubruille
View author publications
You can also search for this author in PubMed Google Scholar
Ian W. Flinn
View author publications
You can also search for this author in PubMed Google Scholar
Slawomira Kyrcz-Krzemien
View author publications
You can also search for this author in PubMed Google Scholar
Ewa Medras
View author publications
You can also search for this author in PubMed Google Scholar
Maria Zanichelli
View author publications
You can also search for this author in PubMed Google Scholar
Israel Bendit
View author publications
You can also search for this author in PubMed Google Scholar
Silvia Cacciatore
View author publications
You can also search for this author in PubMed Google Scholar
Ksenia Titorenko
View author publications
You can also search for this author in PubMed Google Scholar
Paola Aimone
View author publications
You can also search for this author in PubMed Google Scholar
Giuseppe Saglio
View author publications
You can also search for this author in PubMed Google Scholar
Andreas Hochhaus
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hagop M. Kantarjian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kantarjian, H.M., Hughes, T.P., Larson, R.A. et al. Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis. Leukemia 35, 2142–2143 (2021). https://doi.org/10.1038/s41375-021-01306-1

Download citation

Published: 09 June 2021
Issue Date: July 2021
DOI: https://doi.org/10.1038/s41375-021-01306-1

Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Search

Quick links

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Quick links